GSK and ViiV Healthcare Pledge £6 Million to Boost Global Fight Against HIV, TB and Malaria Read more
Roche’s Giredestrant Combo Cuts Breast Cancer Progression Risk by Up to 62% in Phase III Trial Read more
Minovia Therapeutics Wins FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome Read more